Dutch Enterprise Chamber orders Wingtech not to interfere at Nexperia as officials sound out investors

Latest: On 11 November 2026, the Enterprise Chamber of the Amsterdam Court of Appeal imposed additional immediate measures, in part backed by significant penalties, on Wingtech TechnologyDealroom has a profile for this one. Try Dealroom →, Nexperia China, Yuching, suspended former chief executive Zhang Xuezheng and members of Wingtech's leadership. According to Nexperia's 12 November statement, the court found that their actions had undermined earlier rulings, hindered NexperiaDealroom has a profile for this one. Try Dealroom →'s ability to exercise its intellectual property rights, restore supply-chain continuity and form partnerships, and constituted an abuse of law.

The orders require those parties to refrain from interfering with Nexperia's normal business, including partnerships, capacity expansion, intellectual property licensing, financing and the ordinary management or disposal of assets; to respect the powers of the independent court-appointed officials, Guido Dierick and Arnold Croiset van Uchelen, including their work on a possible long-term solution; to allow them to explore market interest; to withdraw claims in China insofar as those seek to undermine earlier Dutch rulings; and to refrain from enforcing Dongguan court injunctions of 2 November 2026 that would block the sale, transfer or encumbrance of Nexperia intellectual property or assets, or steps toward a long-term solution. Reuters reported that Wingtech could not immediately be reached for comment.

What happens next: In a separate statement, the court-appointed officials said they will assess investor interest in a majority or a minority stake. They said no decision has been taken to reduce Wingtech's ownership interest. They also said they are not currently preparing a sale of a majority stake or a split of Nexperia into Chinese and non-Chinese businesses, and that they regretted Wingtech referring to confidential talks in Chinese proceedings and in a 4 November shareholder update, in ways they believe misrepresented those discussions.

Context: The dispute dates to September 2025, when the Dutch government, then under economic affairs minister Vincent KarremansDealroom has a profile for this one. Try Dealroom →, intervened at Nexperia under the Goods Availability Act, citing concerns that technology and capacity could be moved out of the Netherlands. In October 2025 the Enterprise Chamber suspended Zhang as a director and transferred all but one of the shares in Nexperia Holding to an independent administrator. In February 2026 it ordered an investigation, saying there were valid reasons to doubt the correctness of policy and conduct at the company. Nexperia's European and Chinese operations have since operated separately.

The legal battle: On 3 November, Nexperia confirmed it had sued Wingtech, Nexperia China and Zhang in the Netherlands, seeking damages it estimates at $2 billion. It alleges that since October 2025 Nexperia China has, under Wingtech's control, operated outside the group's governance and that this has disrupted operations. On 2 November, the Court of The Hague granted Nexperia an injunction barring Nexperia China from relying, within the EU, on a Chinese judgment that would limit Nexperia's intellectual property rights.

The case adds to proceedings in both countries. In May, Wingtech sued Nexperia entities and executives in China, seeking US$1.1B. In August, a Chinese court froze Nexperia equity interests in Chinese subsidiaries. On 2 November a Dongguan court issued injunctions that, according to Nexperia, threatened to restrict the company's activities also outside China.

Wingtech's position: In a 4 November shareholder update, Wingtech said court-appointed officials had proposed a structure under which it would keep control of Nexperia's Chinese companies while outside investors took a controlling interest in the rest, leaving Wingtech as a minority shareholder there. Wingtech rejected that as expropriation. The officials now say that is not a plan they are currently preparing, and that the present split results from actions by Wingtech and Nexperia's local management in China.

The stakes are also high for Wingtech on the Shanghai Stock ExchangeDealroom has a profile for this one. Try Dealroom →. After its auditors issued a disclaimer of opinion over restricted access to Nexperia's overseas records, the exchange warned of delisting, and the firm faces removal if the audit impasse is not resolved by April 2027.

Sources: Nexperia statement, 12 November 2026
Statement from the court-appointed officials, 12 November 2026
Reuters
Techzine
Nexperia statement, 5 November 2026

Image: Nexperia exhibition stand.